Exact Mass: 272.1161
Exact Mass Matches: 272.1161
Found 157 metabolites which its exact mass value is equals to given mass value 272.1161,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sotalol
Sotalol is only found in individuals that have used or taken this drug. It is an adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias (PubChem). Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class I) and cardiac action potential duration prolongation (Vaughan Williams Class I) antiarrhythmic properties. Sotalol is a racemic mixture of d- and l-sotalol. Both isomers have similar Class I antiarrhythmic effects, while the l-isomer is responsible for virtually all of the beta-blocking activity. Sotalol inhibits response to adrenergic stimuli by competitively blocking β1-adrenergic receptors within the myocardium and β2-adrenergic receptors within bronchial and vascular smooth muscle. The electrophysiologic effects of sotalol may be due to its selective inhibition of the rapidly activating component of the potassium channel involved in the repolarization of cardiac cells. The class II electrophysiologic effects are caused by an increase in sinus cycle length (slowed heart rate), decreased AV nodal conduction, and increased AV nodal refractoriness, while the class III electrophysiological effects include prolongation of the atrial and ventricular monophasic action potentials, and effective refractory period prolongation of atrial muscle, ventricular muscle, and atrio-ventricular accessory pathways (where present) in both the anterograde and retrograde directions.
1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene
This compound belongs to the family of Phenanthrenes and Derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene.
7-Hydroxymethyl-12-methylbenz[a]anthracene
This compound belongs to the family of Phenanthrenes and Derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene.
7,12-Dimethylbenz[a]anthracene 5,6-oxide
This compound belongs to the family of Dibenzoxepines. These are compounds containing a dibenzoxepine moiety, which consists of two benzene connected by an oxazepine ring.
Decarbamoylneosaxitoxin
Decarbamoylneosaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.
(2S,4R)-4-(9H-Pyrido[3,4-b]indol-1-yl)-1,2,4-butanetriol
Maillard reaction product from xylose and tryptophan. Maillard reaction product from xylose and tryptophan
Camonagrel
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
Fumarylcarboxamido-L-2,3-diaminopropionyl-L-alanine
threo-3-(4-Hydroxy-3,5-dimethoxyphenyl)-3-ethoxypropane-1,2-diol
3-{[(7-methoxy-2-oxochromen-4-yl)methyl]methylamino}propanenitrile
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.948 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.944 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.946
6-Acetoxy-piliformic-acid
[Raw Data] CBA55_6-Acetoxy-pi_pos_50eV.txt [Raw Data] CBA55_6-Acetoxy-pi_pos_40eV.txt [Raw Data] CBA55_6-Acetoxy-pi_pos_30eV.txt [Raw Data] CBA55_6-Acetoxy-pi_pos_20eV.txt [Raw Data] CBA55_6-Acetoxy-pi_pos_10eV.txt
Tensyuic acid C
A tensyuic acid that is tensyuic acid B in which the methyl ester group has been replaced by an ethyl ester group. The (-) isomer. In contrast to (inactive) tensyuic acid B, tensyuic acid C shows moderate antimicrobial activity against Bacillus subtilis.
2-Thioxo-5-propyl-5-(3-hydroxy-3-methylbutyl)-2,3-dihydropyrimidine-4,6(1H,5H)-dione
11-Hydroxy-1,2,3,4-tetrahydro-1,2-propano-beta-carboline-11-carboxylic acid
2-(1,2,3-trihydroxypropyl)1,2,3,4,5,6-hexahydroxyhexane
2-acetyl-9-methoxy-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5(10H)-one|boseongazepine A
(E)-2-ethylidene-11-hydroxy-9-methoxy-2,3-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5(11aH)-one|boseongazepine B
1-(1-hydroxy-2-methoxy)ethyl-4-methoxy-beta-carboline|1-(1-Hydroxy-2-methoxyethyl)-4-methoxy-beta-carboline
Tensyuic acid D
A tensyuic acid that is tensyuic acid B in which the non-conjugated carboxy group has been converted to the corresponding methyl ester. The (+)-isomer, isolated from Aspergillus niger FKI-2342.
sotalol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker CONFIDENCE Reference Standard (Level 1)
(3Z)-3-[(4-hydroxyphenyl)methylidene]-2-methyl-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazine-1,4-dione
PYR_273.1235_11.5
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1704
4-{9H-pyrido[3,4-b]indol-1-yl}butane-1,2,4-triol
2(1H)-Pyrimidinone,5-acetyl-4-(3-ethenyl-2-hydroxyphenyl)-3,4-dihydro-6-methyl-(9CI)
(+)-(s)-n-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide
(6-HYDROXY-5-(TETRAHYDRO-2H-PYRAN-2-YL)NAPHTHALEN-2-YL)BORONIC ACID
4,4,5,5-TETRAMETHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE
4,4,5,5-TETRAMETHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE
4,4,5,5-TETRAMETHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE
4-[(1-PHENYL-ETHYLAMINO)-METHYL]-BENZONITRILE HYDROCHLORIDE
7-Benzyl-2-methyl-2,7-diazaspiro[4.4]nonane-1,3,8-trione
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
(3-Amino-5-(diethylcarbamoyl)phenyl)boronic acid hydrochloride
ethenyl acetate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid
2-CHLORO-6,7,8,9-TETRAHYDRO-7-(PHENYLMETHYL)-5H-PYRIDO[2,3-D]AZEPINE
L-Alanine, N-L-alanyl-3-((4-amino-1,4-dioxo-2-butenyl)amino)-, (E)-
5-[(2,3-dihydro-1H-inden-5-yloxy)methyl]-2-furohydrazide
9,10-Dimethoxy-2,4,6,7-tetrahydro-[1,3]oxazino[4,3-a]isoquinoline-1-carbonitrile
N-{2-[6-methyl-3-(methylsulfanyl)-1,2,4-triazin-5-yl]vinyl}-N-(4-methylphenyl)amine
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 4,4a,5,6-tetrahydro-1-oxo-, ethyl ester
(2S)-3-[[(E)-4-amino-4-oxobut-2-enoyl]amino]-2-[[(2S)-2-azaniumylpropanoyl]amino]propanoate
2,6-diamino-4-(hydroxymethyl)-5-oxido-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-5-ium-10,10-diol
N-(3-acetylphenyl)-5-propan-2-yl-3-isoxazolecarboxamide
(3Z)-3-[(4-hydroxyphenyl)methylidene]-2-methyl-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazine-1,4-dione
(3aS,4R,10aS)-2-amino-5-hydroxy-4-(hydroxymethyl)-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purine-10,10-diol
6-Methoxymethyl-2,3,4-trimethoxybenzyl methyl sulfide
1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene
(2S,4R)-4-(9H-Pyrido[3,4-b]indol-1-yl)-1,2,4-butanetriol
N-(gamma-L-glutamyl)-2-naphthylamine
An L-glutamine derivative that is the amide obtained by formal condensation of the gamma-carboxy group of L-glutamic acid with the amino group of 2-naphthylamine.
